Literature DB >> 12198707

The type of sodium-coupled solute modulates small bowel mucosal injury, transport function, and ATP after ischemia/reperfusion injury in rats.

Rosemary A Kozar1, Stanley G Schultz, Heitham T Hassoun, Roland Desoignie, Norman W Weisbrodt, Marian M Haber, Frederick A Moore.   

Abstract

BACKGROUND & AIMS: Gastrointestinal function may be impaired after severe injury, hampering tolerance to enteral nutrition. The purpose of this study was to determine how different sodium-coupled solutes modulate gut function after ischemia/reperfusion (I/R) in a rodent model.
METHODS: At laparotomy, rats had jejunal sacs filled with (glucose + alanine), glucose, glutamine, alanine, or mannitol (osmotic control), followed by superior mesenteric artery clamping for 60 minutes and 30 minutes of reperfusion. After reperfusion, sacs were harvested for morphologic examination, adenosine triphosphate (ATP) assay, or mounted in an Ussing chamber.
RESULTS: Small intestinal epithelial absorptive capacity, as assessed by changes in short-circuit current in response to glucose, after gut I/R, was decreased by alanine or (glucose + alanine) but not glucose or glutamine alone and correlated with changes in tissue ATP. Gut I/R caused a significant morphologic injury that was worsened by alanine or (glucose + alanine) but lessened by glucose or glutamine alone.
CONCLUSIONS: During gut I/R, alanine can enhance gut injury, deplete energy (ATP), and impair gut absorption, whereas glucose or glutamine is protective against injury and can maintain absorptive capacity and ATP. These results suggest that solutes (such as alanine), which further stress an already metabolically stressed bowel, should be cautiously administered to critically ill patients whereas those solutes that contribute to energy production (such as glucose and glutamine) may be safely continued.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198707     DOI: 10.1053/gast.2002.35389

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  12 in total

1.  Protection by enteral glutamine is mediated by intestinal epithelial cell peroxisome proliferator-activated receptor-γ during intestinal ischemia/reperfusion.

Authors:  Zhanglong Peng; Kechen Ban; Richard A Wawrose; Adam G Gover; Rosemary A Kozar
Journal:  Shock       Date:  2015-04       Impact factor: 3.454

2.  Differential effects of luminal arginine and glutamine on metalloproteinase production in the postischemic gut.

Authors:  Emily K Robinson; Daniel P Kelly; David W Mercer; Rosemary A Kozar
Journal:  JPEN J Parenter Enteral Nutr       Date:  2008 Jul-Aug       Impact factor: 4.016

3.  Glutamine activates peroxisome proliferator-activated receptor-γ in intestinal epithelial cells via 15-S-HETE and 13-OXO-ODE: a novel mechanism.

Authors:  Kechen Ban; Julie M Sprunt; Stephanie Martin; Peiying Yang; Rosemary A Kozar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-07-07       Impact factor: 4.052

4.  Syndecan 1 plays a novel role in enteral glutamine's gut-protective effects of the postischemic gut.

Authors:  Zhanglong Peng; Kechen Ban; Aritra Sen; Raymond Grill; Pyong Park; Todd W Costantini; Rosemary Kozar
Journal:  Shock       Date:  2012-07       Impact factor: 3.454

Review 5.  Oxygen in the regulation of intestinal epithelial transport.

Authors:  Joseph B J Ward; Simon J Keely; Stephen J Keely
Journal:  J Physiol       Date:  2014-04-07       Impact factor: 5.182

6.  Glutamine protects against apoptosis via downregulation of Sp3 in intestinal epithelial cells.

Authors:  Kechen Ban; Rosemary A Kozar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-30       Impact factor: 4.052

Review 7.  Molecular mechanisms of pharmaconutrients.

Authors:  Rachel Santora; Rosemary A Kozar
Journal:  J Surg Res       Date:  2009-07-17       Impact factor: 2.192

8.  Distinct cytoprotective roles of pyruvate and ATP by glucose metabolism on epithelial necroptosis and crypt proliferation in ischaemic gut.

Authors:  Ching-Ying Huang; Wei-Ting Kuo; Chung-Yen Huang; Tsung-Chun Lee; Chin-Tin Chen; Wei-Hao Peng; Kuo-Shyan Lu; Chung-Yi Yang; Linda Chia-Hui Yu
Journal:  J Physiol       Date:  2016-06-17       Impact factor: 5.182

9.  Intraluminal tranexamic acid inhibits intestinal sheddases and mitigates gut and lung injury and inflammation in a rodent model of hemorrhagic shock.

Authors:  Zhanglong Peng; Kechen Ban; Anthony LeBlanc; Rosemary A Kozar
Journal:  J Trauma Acute Care Surg       Date:  2016-08       Impact factor: 3.313

Review 10.  Enteral glutamine: a novel mediator of PPARgamma in the postischemic gut.

Authors:  Kechen Ban; Rosemary A Kozar
Journal:  J Leukoc Biol       Date:  2008-04-07       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.